Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hyperparathyroidism
Phenotype C0027662|multiple endocrine neoplasia
Sentences 15
PubMedID- 26031271 Primary hyperparathyroidism in multiple endocrine neoplasia type i usually affects all parathyroid glands, making focused parathyroidectomy (fp) inappropriate.
PubMedID- 20431882 Background: subtotal parathyroidectomy (sptx) is the treatment of choice for hyperparathyroidism in a patient with multiple endocrine neoplasia type 1 (hpt-men-1).
PubMedID- 22584713 Primary hyperparathyroidism associated with multiple endocrine neoplasia type i (hyperparathyroidism/multiple endocrine neoplasia type 1) differs in many aspects from sporadic hyperparathyroidism, which is the most frequently occurring form of hyperparathyroidism.
PubMedID- 21318141 Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
PubMedID- 22584724 Further, as far as we know, only two studies have consistently evaluated bone mineral density values after parathyroidectomy in cases of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1.
PubMedID- 22584719 Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery.
PubMedID- 20570815 Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2a.
PubMedID- 19650788 Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy.
PubMedID- 24581877 [severe maintained hypocalcemia after parathyroidectomy for hyperparathyroidism in a patient with multiple endocrine neoplasia i and prior bariatric surgery].
PubMedID- 22735224 Objective: to evaluate frequency, anatomic presentation, and quantities of supernumerary parathyroids glands in patients with primary hyperparathyroidism (hpt1) associated with multiple endocrine neoplasia type 1 (men1), as well as the importance of thymectomy, and the benefits of localizing examinations for those glands.
PubMedID- 25262224 A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
PubMedID- 24037737 A 59-year-old woman with classic manifestations of hyperparathyroidism associated with multiple endocrine neoplasia type 1 presented with a right adrenal mass and two pituitary microadenomas on imaging studies.
PubMedID- 23363383 Also covered is the role of pharmacotherapy in controlling acid hypersecretion and other hormonal hypersecretory states these patients may develop, including hyperparathyroidism in patients with multiple endocrine neoplasia type 1 and zes; tumor localization; and the treatment of advanced metastatic disease.
PubMedID- 22584718 Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center.
PubMedID- 22281890 Although hyperparathyroidism in multiple endocrine neoplasia 1 (men1) syndrome is the most common manifestation, parathyroid carcinoma is rare.

Page: 1